Silence Therapeutics PLC
OTC:SLNCF

Watchlist Manager
Silence Therapeutics PLC Logo
Silence Therapeutics PLC
OTC:SLNCF
Watchlist
Price: 5.79 USD 3.39% Market Closed
Market Cap: 812.9m USD
Have any thoughts about
Silence Therapeutics PLC?
Write Note

Silence Therapeutics PLC
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Silence Therapeutics PLC
Interest Income Expense Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Silence Therapeutics PLC
OTC:SLNCF
Interest Income Expense
-ÂŁ136k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Interest Income Expense
$570k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Interest Income Expense
-$29m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Interest Income Expense
$27.8m
CAGR 3-Years
N/A
CAGR 5-Years
110%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Interest Income Expense
-ÂŁ344k
CAGR 3-Years
21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Interest Income Expense
-ÂŁ200k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
24%

See Also

What is Silence Therapeutics PLC's Interest Income Expense?
Interest Income Expense
-136k GBP

Based on the financial report for Dec 31, 2019, Silence Therapeutics PLC's Interest Income Expense amounts to -136k GBP.

Back to Top